PMCTPharmaCountry
    Home

Analysis

In-depth analysis of pharmaceutical markets, supply chains, technology and regulation

#2239 ×

Analysis
Aug 30, 2026•1 min read
Vertex Pharmaceuticals to Acquire Crinetics for $10B, Securing Palsonify and CAH Candidate
Vertex Pharma announced a $10 billion acquisition of Crinetics, adding the potential blockbuster Palsonify and ACTH‑receptor antagonist atumelnant for congenital adrenal hyperplasia.